NCT01028963 - A Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Type 2 Diabetes Mellitus | Biotech Hunter

Enrollment

159

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

October 31, 2010

Study Completion Date

November 30, 2010

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

Placebo

Placebo capsules once daily

DRUG

pioglitazone

pioglitazone 30 mg tablet once daily

DRUG

CCX140-B

CCX140-B capsules once daily (Group C)

DRUG

CCX140-B

CCX140-B capsules once daily (Group D)

Trial Locations (28)

Unknown

Auchenflower

Kippa-Ring

Beroun

Hlučín

Neratovice

Nový Jičín

Ostrava

Pardubice

Prague

Přelouč

Slaný

Uherský Brod

Uničov

Ústí nad Labem

Basenheim

Berlin

Cologne

Dresden

Heidelberg

Mannheim

Nuremberg

Saarlouis

Balatonfüred

Budapest

Sátoraljaújhely

Szikszó

Christchurch

Wellington